Literature DB >> 21090242

[Downregulation of activated leukemic oncogenes AML1-ETO and RUNX1(K83N) expression with RNA-interference].

P V Spirin, F Baskaran, N N Orlova, A V Rulina, N A Nikitenko, E L Chernolovskaia, M A Zenkova, V V Vlasov, P M Rubtsov, P M Chumakov, C Stocking, V S Prasolov.   

Abstract

In the present study we have applied the siRNA approach for substantial reduction of AML1-ETO and RUNX1 (K83N) expression, which are frequently found in the leukemic cells. We have designed small hairpin RNAs (shRNA) for targeting AML1-ETO oncogene and a region close to the 5'-untranslated region of mRNA for the mutant RUNX1 (K83N) oncogene and expressed the shRNAs in lentiviral vectors. We report a stable reduction in expression of the oncogenes following the introduction of shRNAs into cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21090242

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  3 in total

1.  Deregulation of RAD21 and RUNX1 expression in endometrial cancer.

Authors:  Anna Supernat; Sylwia Lapińska-Szumczyk; Sambor Sawicki; Dariusz Wydra; Wojciech Biernat; Anna J Zaczek
Journal:  Oncol Lett       Date:  2012-07-09       Impact factor: 2.967

2.  Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling.

Authors:  P V Spirin; T D Lebedev; N N Orlova; A S Gornostaeva; M M Prokofjeva; N A Nikitenko; S E Dmitriev; A A Buzdin; N M Borisov; A M Aliper; A V Garazha; P M Rubtsov; C Stocking; V S Prassolov
Journal:  Leukemia       Date:  2014-04-14       Impact factor: 11.528

3.  A new system for parallel drug screening against multiple-resistant HIV mutants based on lentiviral self-inactivating (SIN) vectors and multi-colour analyses.

Authors:  Boris Fehse; Carol Stocking; Vladimir S Prassolov; Maria M Prokofjeva; Kristoffer Riecken; Pavel V Spirin; Dimitriy V Yanvarév; Arne Düsedau; Bernhard Ellinger
Journal:  AIDS Res Ther       Date:  2013-01-03       Impact factor: 2.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.